SeQuent Scientific shares gain 7% on merger update; check key details here

Don't want to miss the best from Business Standard?

SeQuent Scientific Share Price Today: Shares of pharmaceutical company SeQuent Scientific were in strong demand on the bourses on Thursday, November 27, after the company said in an exchange filing that it has fixed the record date for the merger scheme approved by the National Company Law Tribunal (NCLT). The stock rose 7.44 per cent to ₹235.6 during intraday trade.

 

Even with the sharp rise, the shares remain nearly 9 per cent below their 52-week high of ₹257.85, which was hit earlier this month on November 18 on the NSE.

 

The counter continued to attract buying interest on Thursday. At 11.52 AM, SeQuent Scientific shares were trading at ₹227.90, up 3.93 per cent from the previous close of ₹219.28 on the NSE. The benchmark Nifty 50 was up 31.95 points or 0.12 per cent at 26,237.

 

A combined total of 3.22 million equity shares of the pharma company worth ₹72 crore had changed hands on the NSE and BSE by midday.

SeQuent Scientific merger details

The company said in its exchange filing that Monday, December 8, 2025, has been fixed as Record Date 2 to determine the shareholders of Viyash who will be eligible for the allotment of Merger Consideration Shares 2.

 

The share exchange ratio under this leg of the merger is 56 equity shares of SeQuent with a face value of ₹2 each fully paid for every 100 equity shares of Viyash with a face value of ₹10 each fully paid, as per the exchange filing submitted by the company. 

 

Earlier on November 18, SeQuent Scientific and Viyash Lifesciences Private Limited announced through an exchange filing that the NCLT has approved the merger scheme between SeQuent and the Viyash group of companies.

 

The company had earlier informed the exchanges that Viyash fixed Saturday, November 1, 2025, as Record Date 1 to determine the equity shareholders of Geninn who will be entitled to receive equity shares from Viyash as Merger Consideration Shares 1.

 

The share exchange ratio for this portion of the merger is 47 equity shares of Viyash with a face value of ₹10 each fully paid for every 1 equity share of Geninn with a face value of ₹10 each fully paid.